Related Experiment Video
Updated: Jan 24, 2026

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
MicroRNA-628-5p inhibits cell proliferation in glioma by targeting DDX59
Peng Xie1, Yan Wang2, Yuanmei Liao3
1Department of Neurosurgery, The Second People's Hospital of Huai'an, The Affiliated Huai'an Hospital of Xuzhou Medical University, Huai'an, China.
Abstract:
Recent study has reported that microRNA-628-5p (miR-628-5p) is involved in the development of epithelial ovarian cancer; however, the mechanisms of miR-628-5p in glioma remain unclear. In this study, we explored the potential biological roles of miR-628-5p in glioma. First, we found that miR-628-5p was decreased in the tissues and cells (U87 and T98) of glioma. Second, overexpressing miR-628-5p reduced the ability of glioma cells' proliferation and induced glioma cells' cycle arrest in G1. Then, we found that miR-628-5p directly bound to the 3'-untranslated region of DDX59 and decreased the protein level of DDX59. The decrease of DDX59 was found to lead to the decrease of p-AKT. Mechanistic studies revealed that restoring the expression of DDX59 alleviated miR-628-5p-induced inhibition of proliferation of glioma. These findings suggest that the miR-628-5p/DDX59 axis has a key role in the development of glioma, and miR-628-5p might be a new therapeutic target against glioma.
Insights
MicroRNA-628-5p (miR-628-5p) is downregulated in glioma, inhibiting cancer cell proliferation and survival. Restoring miR-628-5p levels may offer a novel therapeutic strategy for glioma treatment.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- microRNA-628-5p (miR-628-5p) has been implicated in epithelial ovarian cancer.
- The specific role and mechanisms of miR-628-5p in glioma remain largely unexplored.
Purpose of the Study:
- To investigate the biological functions and underlying mechanisms of miR-628-5p in glioma development.
- To determine if miR-628-5p could serve as a potential therapeutic target for glioma.
Main Methods:
- Quantitative real-time PCR to assess miR-628-5p expression in glioma tissues and cell lines (U87, T98).
- Cell proliferation assays and cell cycle analysis to evaluate the functional impact of miR-628-5p.
- Western blotting to measure protein levels of DDX59 and p-AKT.
- Luciferase reporter assays to confirm direct binding of miR-628-5p to the DDX59 3'-UTR.
Main Results:
- miR-628-5p expression was significantly decreased in glioma tissues and cells compared to normal controls.
- Overexpression of miR-628-5p suppressed glioma cell proliferation and induced G1 cell cycle arrest.
- miR-628-5p directly targets DDX59, leading to reduced DDX59 protein levels and subsequently decreased p-AKT.
- Restoration of DDX59 expression attenuated the inhibitory effects of miR-628-5p on glioma cell proliferation.
Conclusions:
- The miR-628-5p/DDX59 axis plays a critical role in glioma pathogenesis.
- miR-628-5p functions as a tumor suppressor in glioma by inhibiting proliferation and promoting cell cycle arrest.
- miR-628-5p represents a promising novel therapeutic target for glioma treatment.
Related Concept Videos
MicroRNAs
MicroRNAs
Feedback Inhibition
Cells Coordinate Growth and Proliferation
Abnormal Proliferation
Enzyme Inhibition

